These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26380316)

  • 1. Adsorption of Toll-Like Receptor 4 Agonist to Alum-Based Tetanus Toxoid Vaccine Dampens Pro-T Helper 2 Activities and Enhances Antibody Responses.
    Bortolatto J; Mirotti L; Rodriguez D; Gomes E; Russo M
    J Immunol Res; 2015; 2015():280238. PubMed ID: 26380316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
    Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
    Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
    Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
    Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
    Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J
    Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic vaccination with adjuvant monophosphoryl lipid a prevents Th2-mediated murine asthmatic responses.
    Wu CJ; Chou HW; Liou CJ; Shen JJ; Wang LC; Kuo ML
    J Asthma; 2013 May; 50(4):327-33. PubMed ID: 23343407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.
    Bickert T; Trujillo-Vargas CM; Duechs M; Wohlleben G; Polte T; Hansen G; Oelschlaeger TA; Erb KJ
    Int Arch Allergy Immunol; 2009; 149(3):219-30. PubMed ID: 19218814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR9 agonist adsorbed to alum adjuvant prevents asthma-like responses induced by Blomia tropicalis mite extract.
    Nunes FPB; Alberca-Custódio RW; Gomes E; Fonseca DM; Yokoyama NH; Labrada A; Russo M
    J Leukoc Biol; 2019 Sep; 106(3):653-664. PubMed ID: 31329326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.
    Katare YK; Panda AK
    Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
    Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J
    Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant-Induced Th2 Responses.
    Miki H; Nakahashi-Oda C; Sumida T; Shibuya A
    J Immunol; 2015 Jun; 194(11):5069-76. PubMed ID: 25911756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice.
    Przetak M; Chow J; Cheng H; Rose J; Hawkins LD; Ishizaka ST
    Vaccine; 2003 Feb; 21(9-10):961-70. PubMed ID: 12547609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
    Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.
    Inglefield J; Catania J; Harris A; Hickey T; Ma Z; Minang J; Baranji K; Spangler T; Look J; Ruiz C; Lu H; Alleva D; Reece JJ; Lacy MJ
    Vaccine; 2022 Sep; 40(38):5544-5555. PubMed ID: 35773119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide Inhibits FI-RSV Vaccine-enhanced Inflammation Through Regulating Th Responses.
    Yin W; Li HY; Zheng BY; Deng YQ; Li WJ; Liu Y; Zeng RH
    Curr Med Sci; 2019 Jun; 39(3):363-370. PubMed ID: 31209804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
    Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
    Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
    Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
    Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
    Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
    Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.